Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
24.82 USD | -1.31% |
|
-.--% | +19.67% |
05:22pm | Generali buys shares for nearly EUR8 million | AN |
24/06 | Generali buys back own shares for approximately EUR33 million | AN |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- With a P/E ratio at 9.44 for the current year and 8.69 for next year, earnings multiples are highly attractive compared with competitors.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+19.67% | 3.85TCr | - | ||
+6.00% | 7.21TCr | B- | ||
+8.10% | 5.07TCr | B | ||
+5.78% | 4.99TCr | B+ | ||
+24.42% | 4.76TCr | B+ | ||
+13.24% | 4.21TCr | B+ | ||
+20.02% | 3.3TCr | B | ||
-2.39% | 2.84TCr | B | ||
-9.01% | 2.72TCr | B- | ||
+26.99% | 2.66TCr | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- G Stock
- ARZGF Stock
- Ratings Generali